Predicting Hepatitis B Virus Infection Based on Health Examination Data of Community Population

Author:

Wang Ying,Du Zhicheng,Lawrence Wayne R.ORCID,Huang Yun,Deng Yu,Hao YuantaoORCID

Abstract

Despite a decline in the prevalence of hepatitis B in China, the disease burden remains high. Large populations unaware of infection risk often fail to meet the ideal treatment window, resulting in poor prognosis. The purpose of this study was to develop and evaluate models identifying high-risk populations who should be tested for hepatitis B surface antigen. Data came from a large community-based health screening, including 97,173 individuals, with an average age of 54.94. A total of 33 indicators were collected as model predictors, including demographic characteristics, routine blood indicators, and liver function. Borderline-Synthetic minority oversampling technique (SMOTE) was conducted to preprocess the data and then four predictive models, namely, the extreme gradient boosting (XGBoost), random forest (RF), decision tree (DT), and logistic regression (LR) algorithms, were developed. The positive rate of hepatitis B surface antigen (HBsAg) was 8.27%. The area under the receiver operating characteristic curves for XGBoost, RF, DT, and LR models were 0.779, 0.752, 0.619, and 0.742, respectively. The Borderline-SMOTE XGBoost combined model outperformed the other models, which correctly predicted 13,637/19,435 cases (sensitivity 70.8%, specificity 70.1%), and the variable importance plot of XGBoost model indicated that age was of high importance. The prediction model can be used to accurately identify populations at high risk of hepatitis B infection that should adopt timely appropriate medical treatment measures.

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference36 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. Global Hepatitis Reporthttps://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

3. New Hepatitis B Treatment Guidelines Released in Chinahttps://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

4. Cost of Chronic Hepatitis B Infection in China

5. Global Health Sector Strategy on Viral Hepatitis 2016–2021https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Cohort Profile: The Pearl River Cohort Study;International Journal of Epidemiology;2024-08-14

2. Development and validation of HBV surveillance models using big data and machine learning;Annals of Medicine;2024-02-10

3. Machine learning for prediction of viral hepatitis: A systematic review and meta-analysis;International Journal of Medical Informatics;2023-11

4. Explainable Machine Learning Techniques To Predict Amiodarone-Induced Thyroid Dysfunction Risk: Multicenter, Retrospective Study With External Validation;Journal of Medical Internet Research;2023-02-07

5. Diagnosis Hepatitis B Using Machine and Deep Learning: Survey;Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3